These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 18378121)

  • 21. The Therapeutic Potential of D-Amino Acid Oxidase (DAAO) Inhibitors.
    Smith SM; Uslaner JM; Hutson PH
    Open Med Chem J; 2010 May; 4():3-9. PubMed ID: 20648222
    [TBL] [Abstract][Full Text] [Related]  

  • 22. D-Amino-Acid Oxidase Inhibition Increases D-Serine Plasma Levels in Mouse But not in Monkey or Dog.
    Rojas C; Alt J; Ator NA; Thomas AG; Wu Y; Hin N; Wozniak K; Ferraris D; Rais R; Tsukamoto T; Slusher BS
    Neuropsychopharmacology; 2016 May; 41(6):1610-9. PubMed ID: 26471255
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human d-amino acid oxidase: The inactive G183R variant.
    Murtas G; Caldinelli L; Cappelletti P; Sacchi S; Pollegioni L
    Biochim Biophys Acta Proteins Proteom; 2018 Jul; 1866(7):822-830. PubMed ID: 29274788
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics of oral D-serine in D-amino acid oxidase knockout mice.
    Rais R; Thomas AG; Wozniak K; Wu Y; Jaaro-Peled H; Sawa A; Strick CA; Engle SJ; Brandon NJ; Rojas C; Slusher BS; Tsukamoto T
    Drug Metab Dispos; 2012 Nov; 40(11):2067-73. PubMed ID: 22837388
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oral administration of D-alanine in monkeys robustly increases plasma and cerebrospinal fluid levels but experimental D-amino acid oxidase inhibitors had minimal effect.
    Rojas C; Alt J; Ator NA; Wilmoth H; Rais R; Hin N; DeVivo M; Popiolek M; Tsukamoto T; Slusher BS
    J Psychopharmacol; 2016 Sep; 30(9):887-95. PubMed ID: 27287825
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation of D-amino acid oxidase expression in the yeast Rhodotorula gracilis.
    Molla G; Motteran L; Piubelli L; Pilone MS; Pollegioni L
    Yeast; 2003 Sep; 20(12):1061-9. PubMed ID: 12961754
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeting D-Amino Acid Oxidase (DAAO) for the Treatment of Schizophrenia: Rationale and Current Status of Research.
    Kuo CY; Lin CH; Lane HY
    CNS Drugs; 2022 Nov; 36(11):1143-1153. PubMed ID: 36194364
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential effects of DAAO on regional activation and functional connectivity in schizophrenia, bipolar disorder and controls.
    Papagni SA; Mechelli A; Prata DP; Kambeitz J; Fu CH; Picchioni M; Walshe M; Toulopoulou T; Bramon E; Murray RM; Collier DA; Bellomo A; McGuire P
    Neuroimage; 2011 Jun; 56(4):2283-91. PubMed ID: 21421061
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Discovery of isatin and 1H-indazol-3-ol derivatives as d-amino acid oxidase (DAAO) inhibitors.
    Szilágyi B; Kovács P; Ferenczy GG; Rácz A; Németh K; Visy J; Szabó P; Ilas J; Balogh GT; Monostory K; Vincze I; Tábi T; Szökő É; Keserű GM
    Bioorg Med Chem; 2018 May; 26(8):1579-1587. PubMed ID: 29472125
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lamina-specific abnormalities of NMDA receptor-associated postsynaptic protein transcripts in the prefrontal cortex in schizophrenia and bipolar disorder.
    Beneyto M; Meador-Woodruff JH
    Neuropsychopharmacology; 2008 Aug; 33(9):2175-86. PubMed ID: 18033238
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Selenoprotein W as a molecular target of d-amino acid oxidase is regulated by d-amino acid in chicken neurons.
    Li W; Talukder M; Sun XT; Zhang C; Li XN; Ge J; Li JL
    Metallomics; 2018 May; 10(5):751-758. PubMed ID: 29766197
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of human DAAO variants potentially related to an increased risk of schizophrenia.
    Caldinelli L; Sacchi S; Molla G; Nardini M; Pollegioni L
    Biochim Biophys Acta; 2013 Mar; 1832(3):400-10. PubMed ID: 23219954
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Determination of D-serine and D-alanine Tissue Levels in the Prefrontal Cortex and Hippocampus of Rats After a Single Dose of Sodium Benzoate, a D-Amino Acid Oxidase Inhibitor, with Potential Antipsychotic and Antidepressant Properties.
    Huang CC; Wei IH; Yang HT; Lane HY
    Neurochem Res; 2023 Jul; 48(7):2066-2076. PubMed ID: 36786942
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structure-function relationships in human D-amino acid oxidase.
    Sacchi S; Caldinelli L; Cappelletti P; Pollegioni L; Molla G
    Amino Acids; 2012 Nov; 43(5):1833-50. PubMed ID: 22865246
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dual role of D-amino acid oxidase in experimental pain models.
    Sharma J; Kulshrestha R; Singh N; Jaggi AS
    Eur J Pharmacol; 2019 Jul; 855():98-102. PubMed ID: 31059710
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Converging Evidence on D-Amino Acid Oxidase-Dependent Enhancement of Hippocampal Firing Activity and Passive Avoidance Learning in Rats.
    Nagy LV; Bali ZK; Kapus G; Pelsőczi P; Farkas B; Lendvai B; Lévay G; Hernádi I
    Int J Neuropsychopharmacol; 2021 May; 24(5):434-445. PubMed ID: 33305805
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Coexpression of Vitreoscilla hemoglobin reduces the toxic effect of expression of D-amino acid oxidase in E. coli.
    Chien LJ; Wu JM; Kuan IC; Lee CK
    Biotechnol Prog; 2004; 20(5):1359-65. PubMed ID: 15458318
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of risperidone on D-amino acid oxidase activity as a hypothesis for a novel mechanism of action in the treatment of schizophrenia.
    Abou El-Magd RM; Park HK; Kawazoe T; Iwana S; Ono K; Chung SP; Miyano M; Yorita K; Sakai T; Fukui K
    J Psychopharmacol; 2010 Jul; 24(7):1055-67. PubMed ID: 19329549
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Decreased levels of D-aspartate and NMDA in the prefrontal cortex and striatum of patients with schizophrenia.
    Errico F; Napolitano F; Squillace M; Vitucci D; Blasi G; de Bartolomeis A; Bertolino A; D'Aniello A; Usiello A
    J Psychiatr Res; 2013 Oct; 47(10):1432-7. PubMed ID: 23835041
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Density of glutamic acid decarboxylase 67 messenger RNA-containing neurons that express the N-methyl-D-aspartate receptor subunit NR2A in the anterior cingulate cortex in schizophrenia and bipolar disorder.
    Woo TU; Walsh JP; Benes FM
    Arch Gen Psychiatry; 2004 Jul; 61(7):649-57. PubMed ID: 15237077
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.